GIP is a hormone that may complement the effects of GLP-1 receptor agonists
A study published in Current Neuropharmacology reveals a potential link between Glucagon-like Peptide-1 (GLP-1) receptor agonists, commonly used in drugs like Ozempic, and an increased risk of depression and suicidal ideation (SI)
2014;5:181 Gunnarsdottir S, Rucki M, Elfarra AA
When youre looking for clarity on peptides, it can feel like wading through jargon
However, healthcare professionals can take measures to reduce discomfort, such as using smaller needles and applying a numbing cream to the injection site
[1] [2] Metabolic adaptation: As the body adjusts to altered glucose metabolism and changes in energy utilisation, temporary fatigue may arise during this transitional period